The field of peptide therapy is experiencing a profound shift with the emergence of AMP (Accelerated Molecule Peptide) chains. These novel compounds are crafted to rapidly traverse biological boundaries, offering the promise for improved drug distribution and targeted therapeutic impact. Early in